Molnupiravir, on its way to be the first oral antiviral medication for COVID-19, could
for those most at risk of contracting severe COVID-19. Merck is seeking approval by the US Food and Drug Administration for the pill.Merck is known by the name MSD outside the US and Canada."We already have secured a budget enough for treatment of around 40,000 people and have signed a pre-purchase deal for 20,000 courses," Kim told a COVID-19 response meeting on Wednesday.Merck said it plans a tiered pricing approach based on country income criteria.
The Korea Disease Control and Prevention Agency had said it was also in talks with Pfizer and Swiss drugmaker Roche Holding AG, who are also racing to develop an easy-to-administer antiviral pill for COVID-19. South Korean government had allocated 36.2 billion won in budget for oral antiviral pills to cure COVID-19. It has been managing its mortality rate - 0.78 per cent as of Tuesday - and critical cases at a fairly low rate.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
South Korea to vaccinate pregnant women as it races to 80% target for adultsSEOUL: South Korea will begin taking reservations for coronavirus vaccines from pregnant women this week as the country accelerates its inoculation drive to reach its goal for immunising 80 per cent of all adults by the end of the month. Health authorities see pregnant mothers as key to the campaign and so
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Thailand in talks with Merck for 200,000 courses of pill for Covid-19 treatment😮😮😮
Source: TODAYonline - 🏆 1. / 99 Read more »
Thailand in talks with Merck for 200,000 courses of pill for COVID-19 treatmentBANGKOK (Reuters) -Thailand's government is in talks with U.S. drugmaker Merck & Co to purchase 200,000 courses of the company's experimental antiviral pill for COVID-19 treatment, a Thai official said on Monday. Many Asian countries are scrambling to lock in supplies of the potential treatment early after they lagged behind Western nations in COVID-19 vaccine rollouts, hit by tight supplies. South Korea, Taiwan and Malaysia said they are all in talks to buy Merck's potential treatment, while the Philippines, which is running a trial on the pill, said it hopes its domestic study would allow access to the treatment.
Source: YahooSG - 🏆 3. / 71 Read more »
Thailand in talks with Merck for 200,000 courses of pill for Covid-19 treatment😮😮😮
Source: TODAYonline - 🏆 1. / 99 Read more »